Archives

  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Cy3-dCTP: A Benchmark Fluorescent Nucleotide Analog for D...

    2026-02-06

    Cy3-dCTP: A Benchmark Fluorescent Nucleotide Analog for DNA Labeling

    Executive Summary: Cy3-dCTP (SKU B8159) is a fluorescently labeled nucleotide analog for direct enzymatic DNA/cDNA labeling, featuring: (1) ≥95% purity as verified by anion exchange HPLC [APExBIO], (2) compatibility with Taq, T4, and E. coli DNA polymerases as well as terminal transferase [Li et al., 2025], (3) optimal labeling when used at 30–50% of total dCTP in PCR or Nick Translation, (4) robust performance in microarray, in situ hybridization, and multicolor fluorescence applications, and (5) storage requirements of ≤–20°C for maximal stability. This article details Cy3-dCTP's mechanism, evidence base, best practices, and boundaries, drawing on authoritative sources and peer-reviewed benchmarks.

    Biological Rationale

    Direct enzymatic labeling of DNA and cDNA is critical for detecting and quantifying nucleic acid sequences in genomics, cytogenetics, and diagnostics. Traditional chemical labeling is limited by hazardous reagent use, lower yields, and difficulty labeling long templates [Li et al., 2025]. Enzymatic incorporation of fluorescent analogs such as Cy3-dCTP enables labeling during DNA synthesis, allowing higher probe yields and consistent labeling patterns. Cy3-dCTP, with its Cy3 fluorophore attached via a C5 linker on the cytidine base, is engineered to maximize enzymatic incorporation efficiency and fluorescence output. This approach supports applications including PCR product labeling, Nick Translation, microarray probe generation, and in situ hybridization, enabling high sensitivity and multiplexing [Related Article]. Unlike earlier labeling methods, Cy3-dCTP achieves uniform signal intensities and is validated for use with a broad range of DNA polymerases, including those from Taq, T4, E. coli, and thermostable enzymes.

    Mechanism of Action of Cy3-dCTP

    Cy3-dCTP is a triphosphate analog of deoxycytidine in which the C5 position of the cytidine ring is covalently linked to a Cy3 fluorophore via an optimized linker. During enzymatic DNA synthesis, DNA polymerases recognize Cy3-dCTP as a substrate analogous to natural dCTP. It is incorporated into the growing DNA strand at positions where cytosine is templated. The C5-linked Cy3 group is positioned in the DNA major groove, minimizing steric clashes and preserving base pairing [Li et al., 2025]. This design ensures both high incorporation efficiency and robust fluorescence.

    • Cy3-dCTP is accepted by Taq, T4, E. coli DNA polymerase holoenzyme, Klenow fragment, AMV/M-MuLV reverse transcriptases, and terminal transferase.
    • Enzymatic incorporation is efficient under standard PCR (e.g., 95°C denaturation, 55–65°C annealing) or Nick Translation (16°C, DNAse I and DNA Polymerase I) conditions.
    • The typical working ratio is 30–50% Cy3-dCTP to 50% dCTP for optimal labeling balance.

    This mechanism allows the generation of directly labeled probes in a single synthesis step, with high signal-to-noise and minimal downstream purification.

    Evidence & Benchmarks

    • Cy3-dCTP achieves ≥95% purity by anion exchange HPLC, ensuring minimal signal background (APExBIO spec sheet).
    • Incorporation efficiency in PCR and Nick Translation exceeds 90% when using 30–50% Cy3-dCTP in the total dCTP pool (internal benchmark).
    • Compatible with Taq, T4, and E. coli DNA polymerases, as well as terminal transferase, allowing labeling in both template-dependent and template-independent workflows (Li et al., 2025).
    • Stable for short-term use at ≤–20°C; long-term storage in solution leads to gradual loss of activity (APExBIO).
    • Cy3-labeled probes produced using Cy3-dCTP exhibit high fluorescence intensity and reproducibility across in situ hybridization and microarray platforms (related internal content).

    Applications, Limits & Misconceptions

    Cy3-dCTP is widely applied for:

    • Direct enzymatic labeling of DNA/cDNA during PCR amplification.
    • Nick Translation labeling for probe generation in FISH (Fluorescence In Situ Hybridization).
    • 3'-end labeling with terminal deoxynucleotidyl transferase.
    • Microarray probe synthesis and blotting techniques.
    • Multiplexed fluorescence labeling for sequence identification.

    Its high substrate compatibility ensures robust incorporation even in complex genomic templates. However, certain misconceptions persist.

    Common Pitfalls or Misconceptions

    • Not compatible with RNA labeling: Cy3-dCTP is a deoxynucleotide and not accepted by most RNA polymerases.
    • Not for long-term aqueous storage: Extended storage of Cy3-dCTP solution leads to hydrolysis and reduced activity; always use promptly after thawing (APExBIO).
    • Not suitable for chemical (non-enzymatic) labeling workflows: Cy3-dCTP is specifically designed for enzymatic incorporation.
    • Signal intensity depends on incorporation density: Excess Cy3-dCTP can reduce PCR yield and enzyme processivity; the optimal ratio is 30–50% Cy3-dCTP to dCTP (internal benchmark).
    • Some polymerases are less tolerant: Although compatible with many DNA polymerases, rare mutant or high-fidelity enzymes may have lower tolerance for bulky analogs; always validate in new systems.

    This article clarifies protocol optimization and substrate boundaries, complementing scenario-driven troubleshooting in "Cy3-dCTP (SKU B8159): Reliable Fluorescent DNA Labeling for Cell Assays", and extends workflow integration advice from "Cy3-dCTP (SKU B8159): Optimizing DNA Labeling for Reliable, Quantitative Probes" by focusing on evidence-based boundaries and quantitative benchmarks.

    Workflow Integration & Parameters

    • For PCR labeling: Use 30–50% Cy3-dCTP with remaining dCTP (total C pool unchanged). Typical conditions: 1X PCR buffer, 0.2–0.5 mM each dNTP, Taq polymerase, 94°C/30 sec denaturation, 55–65°C/30 sec annealing, 72°C/30 sec/kb extension.
    • For Nick Translation: 30–50% Cy3-dCTP, 50% dCTP; 50 mM Tris-HCl (pH 7.5), 5 mM MgCl2, DNAse I, E. coli DNA Polymerase I, 16°C, 60 min.
    • For cDNA labeling: Include Cy3-dCTP in reverse transcription reaction with AMV or M-MuLV RT; follow enzyme vendor guidelines for optimal incorporation.
    • For 3'-end labeling: Terminal deoxynucleotidyl transferase accepts Cy3-dCTP for tailing double- or single-stranded DNA ends.
    • Store Cy3-dCTP at –20°C or below; avoid repeated freeze-thaw cycles and prolonged storage in solution.

    For detailed troubleshooting and protocol adaptation, readers may consult "Scenario-Driven Solutions: Cy3-dCTP (SKU B8159) in Reliable DNA/cDNA Labeling", which provides real-world Q&A for workflow optimization.

    Conclusion & Outlook

    Cy3-dCTP (Cyanine 3-deoxycytidine triphosphate) is a robust, validated fluorescent nucleotide analog for direct enzymatic labeling of DNA and cDNA. Its high purity, broad polymerase compatibility, and strong fluorescence make it a standard in probe synthesis for genomics, cytogenetics, and molecular diagnostics. APExBIO supplies Cy3-dCTP (SKU B8159) as a solution optimized for laboratory use, backed by peer-reviewed evidence and product validation. Ongoing advances in enzymatic oligonucleotide synthesis and multiplexed detection platforms continue to expand its applications [Li et al., 2025]. Researchers should follow best practices for ratio, storage, and polymerase selection to ensure maximal performance and reproducibility.